Otezla

INFORMATION FOR OTEZLA® (apremilast) PATIENTS

This site is designed to provide patients who have been prescribed Otezla® (apremilast) with information about the treatment and other useful materials. Should you have any concerns or questions regarding your treatment with Otezla®, please speak to your doctor or nurse.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient leaflet. Side effects can be reported directly to the Health Products Regulatory Authority (HPRA) using the available methods via www.hpra.ie. Side effects should also be reported to Amgen Limited on +44 (0) 1223 436441 or Freephone 1800 535 160. By reporting side effects you can help provide more information on the safety of this medicine.

Patient Resources

Your guide to Otezla® (apremilast)
An useful guide to help you understand and manage your treatment with Otezla®.
Download PDF
For a list of possible side effects, please see the patient information leaflet (PIL).

This site is intended for patients in Ireland who are being treated with an Amgen® product and for Irish Healthcare Professionals (HCPs).

I am a member of the public
IE-CBU-0820-00002 August 2020